The Enterprise Value as of November 2024 (TTM) for Endonovo Therapeutics, Inc. (ENDV) is 7.37M

According to Endonovo Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.37M. This represents a change of -20.05% compared to the average of 9.21M of the last 4 quarters.

Endonovo Therapeutics, Inc. (ENDV) Historical Enterprise Value (quarterly & annually)

How has ENDV Enterprise Value performed in the past?

The mean historical Enterprise Value of Endonovo Therapeutics, Inc. over the last ten years is 9.27B. The current 7.37M Enterprise Value has changed -92.05% with respect to the historical average. Over the past ten years (40 quarters), ENDV's Enterprise Value was at its highest in in the March 2015 quarter at 93.31B. The Enterprise Value was at its lowest in in the March 2020 quarter at 6.60M.

Endonovo Therapeutics, Inc. (ENDV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Endonovo Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Endonovo Therapeutics, Inc. (ENDV) Average Enterprise Value

How has ENDV Enterprise Value performed in the past?

The current Enterprise Value of Endonovo Therapeutics, Inc. (ENDV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Endonovo Therapeutics, Inc. (ENDV) Enterprise Value vs. Peers

How is ENDV’s Enterprise Value compared to its peers?

Endonovo Therapeutics, Inc.’s Enterprise Value is greater than Bio-Path Holdings, Inc. (-340985.00), less than Cingulate Inc. (11.61M), greater than Purple Biotech Ltd. (-541411.00), less than Soleno Therapeutics, Inc. (2.13B), less than Genelux Corporation (0), less than Comera Life Sciences Holdings, Inc. (100.37M), greater than Dyadic International, Inc. (-1593200.00), less than Monopar Therapeutics Inc. (30.38M), less than Cellectis S.A. (81.10M), less than Biotron Limited (144.28M), less than Bioasis Technologies Inc. (19.39M), less than Covalon Technologies Ltd. (39.49M), less than Mosaic ImmunoEngineering Inc. (85.64M), greater than Quoin Pharmaceuticals, Ltd. (6.48M), greater than Bolt Biotherapeutics, Inc. (3.24M), less than Pasithea Therapeutics Corp. (38.25M), greater than MediciNova, Inc. (-4187996.00), less than Fresh Tracks Therapeutics, Inc. (38.55M), greater than null (-6447751.00),

Build a custom stock screener for Endonovo Therapeutics, Inc. (ENDV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Endonovo Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Endonovo Therapeutics, Inc. (ENDV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Endonovo Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.